Covered recipient · General Payments record
DEBBIE V GREENIDGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2021–2023
$2,107.42
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $729.17 | 25 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $239.65 | 2 |
| ABBVIE INC. | $239.46 | 15 |
| Axsome Therapeutics, Inc. | $124.49 | 1 |
| ITI, Inc. | $53.83 | 3 |
| Almatica Pharma Inc. | $24.47 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $17.15 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.79 | 1 |
| Neurocrine BioSciences, Inc. | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.74 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377153 | CMS |
| ABBVIE INC. | $30.57 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377157 | CMS |
| ABBVIE INC. | $9.65 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377161 | CMS |
| ABBVIE INC. | $82.08 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377165 | CMS |
| ABBVIE INC. | $5.62 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377169 | CMS |
| ABBVIE INC. | $16.00 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377173 | CMS |
| ABBVIE INC. | $2.28 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377177 | CMS |
| ABBVIE INC. | $21.34 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377181 | CMS |
| ABBVIE INC. | $6.43 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377185 | CMS |
| ABBVIE INC. | $13.00 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377189 | CMS |
| ABBVIE INC. | $7.20 | 07/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377193 | CMS |
| ABBVIE INC. | $6.03 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377197 | CMS |
| ABBVIE INC. | $12.21 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377201 | CMS |
| ABBVIE INC. | $10.50 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377205 | CMS |
| ABBVIE INC. | $10.81 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005377209 | CMS |
| Almatica Pharma LLC | $24.47 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993461153 | CMS |
| Axsome Therapeutics, Inc. | $124.49 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056248233 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.15 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034525189 | CMS |
| ITI, Inc. | $15.84 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040919325 | CMS |
| ITI, Inc. | $14.06 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040919333 | CMS |
| ITI, Inc. | $23.93 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040919337 | CMS |
| Janssen Pharmaceuticals, Inc | $124.27 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988130179 | CMS |
| Janssen Pharmaceuticals, Inc | $115.38 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988130169 | CMS |
| Neurocrine Biosciences, Inc. | $13.33 | 11/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052287365 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.79 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055858519 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.